AKBM Stock Overview
Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa.
Aker BioMarine AS Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||kr44.85|
|52 Week High||kr59.90|
|52 Week Low||kr40.10|
|1 Month Change||-11.19%|
|3 Month Change||-9.03%|
|1 Year Change||-0.33%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-57.16%|
Recent News & Updates
Estimating The Fair Value Of Aker BioMarine AS (OB:AKBM)
Today we will run through one way of estimating the intrinsic value of Aker BioMarine AS ( OB:AKBM ) by taking the...
|AKBM||NO Food||NO Market|
Return vs Industry: AKBM exceeded the Norwegian Food industry which returned -28.4% over the past year.
Return vs Market: AKBM exceeded the Norwegian Market which returned -4.5% over the past year.
|AKBM Average Weekly Movement||5.3%|
|Food Industry Average Movement||6.5%|
|Market Average Movement||6.7%|
|10% most volatile stocks in NO Market||11.2%|
|10% least volatile stocks in NO Market||3.8%|
Stable Share Price: AKBM is not significantly more volatile than the rest of Norwegian stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: AKBM's weekly volatility (5%) has been stable over the past year.
About the Company
Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa. It operates through two segments, Ingredients and Brands. It provides Superba, a krill-based ingredients for nutraceutical, including phospholipid complex of choline, omega-3s, and antioxidant astaxanthin; QRILL Aqua, a krill-based ingredients for aquaculture; and QRILL Pet, a krill-based ingredients animal feed application.
Aker BioMarine AS Fundamentals Summary
|AKBM fundamental statistics|
Is AKBM overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|AKBM income statement (TTM)|
|Cost of Revenue||US$175.10m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Nov 01, 2022
|Earnings per share (EPS)||0.12|
|Net Profit Margin||3.88%|
How did AKBM perform over the long term?See historical performance and comparison